Mansoor Raza Mirza, MD, on the Potential Role of PARP Inhibition Plus Immunotherapy in Ovarian Cancer

Posted: Monday, June 17, 2019

Mansoor Raza Mirza, MD, of Copenhagen University Hospital, discusses the clinical implications of study findings on using niraparib plus bevacizumab to treat women with recurrent platinum-sensitive ovarian cancer.